Stockscreener 앱 받기
1.56
1.27%
-0.02
전일 마감가:
$1.58
열려 있는:
$1.58
하루 거래량:
901.73K
Relative Volume:
0.50
시가총액:
$599.92M
수익:
$106.34M
순이익/손실:
$-74.66M
주가수익비율:
-1.6421
EPS:
-0.95
순현금흐름:
$-46.12M
1주 성능:
+1.30%
1개월 성능:
+4.70%
6개월 성능:
+25.81%
1년 성능:
-9.83%
1일 변동 폭
$1.55
$1.61
1주일 범위
$1.46
$1.66
52주 변동 폭
$0.92
$1.89
Standard Biotools Inc Stock (LAB) Company Profile
명칭
Standard Biotools Inc
전화
(650) 266-6000
주소
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.56 | 607.61M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-13 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-27 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | 개시 | TD Cowen | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-12 | 개시 | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Standard BioTools Inc. (LAB) Stock Analysis: Navigating a Challenging Market with Innovative Technologies - DirectorsTalk Interviews
Sentiment Recap: Why Standard BioTools Inc stock could rally in 20252025 Growth vs Value & Trade Opportunity Analysis - Bộ Nội Vụ
Standard BioTools (NASDAQ:LAB) Trading 5.6% HigherStill a Buy? - MarketBeat
Why Standard BioTools Inc. stock could outperform in 2025Market Growth Summary & AI Powered Market Trend Analysis - Улправда
Will Standard BioTools Inc. stock benefit from green energy trendsPortfolio Risk Report & Reliable Intraday Trade Alerts - Улправда
User | woonsocketcall.comStandard BioTools Inc.Common Stock (Nasdaq:LAB) Stock Quote - FinancialContent
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue - Sahm
Can Standard BioTools Inc. stock maintain operating marginsLayoff News & Expert-Curated Trade Recommendations - Улправда
Will Standard BioTools Inc. (FLB) stock rise with strong economyJuly 2025 Catalysts & Low Risk High Reward Ideas - Улправда
Is Standard BioTools Inc. stock a buy before product launchesMarket Risk Summary & High Accuracy Investment Signals - ulpravda.ru
Standard BioTools (NASDAQ:LAB) Shares Gap UpShould You Buy? - MarketBeat
Standard BioTools Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2025 - marketscreener.com
Standard BioTools Reports Preliminary Q4, Full-Year Revenue - Nasdaq
Standard BioTools Inc. (NASDAQ:LAB) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Standard BioTools (NASDAQ:LAB) & Hinge Health (NYSE:HNGE) Critical Contrast - Defense World
What analysts say about Standard BioTools Inc stockExit Strategy Tips & Investment Portfolio Recommendations - earlytimes.in
User | theeveningleader.comStandard BioTools Inc.Common Stock (Nasdaq:LAB) Stock Quote - markets.financialcontent.com
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 80% - simplywall.st
Standard BioTools: Outlook Still Murky (NASDAQ:LAB) - Seeking Alpha
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% – Here’s Why - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1%What's Next? - MarketBeat
What Standard BioTools Inc.'s (NASDAQ:LAB) 28% Share Price Gain Is Not Telling You - 富途牛牛
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9% – What’s Next? - Defense World
Can Standard BioTools Inc. stock sustain market leadershipWeekly Profit Summary & Detailed Earnings Play Alerts - Улправда
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9%Time to Sell? - MarketBeat
Is Standard BioTools Inc. stock a top pick in earnings seasonIndex Update & Reliable Intraday Trade Alerts - Bölüm Sonu Canavarı
Is Standard BioTools Inc. (FLB) stock bottoming after sell offWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
Will Standard BioTools Inc. stock outperform growth indexesBreakout Watch & Expert Verified Movement Alerts - Улправда
Is Standard BioTools Inc. stock a safe investment in uncertain markets2025 Buyback Activity & Safe Entry Zone Tips - ulpravda.ru
Analysts Set Standard BioTools Inc. (NASDAQ:LAB) Price Target at $1.35 - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Zacks Research - MarketBeat
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - setenews.com
Should investors be concerned about Standard BioTools Inc (LAB)? - uspostnews.com
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 75,000 Shares - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Purchases 125,000 Shares of Stock - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Acquires 150,000 Shares of Stock - MarketBeat
Standard BioTools Inc. Stock (LAB) Opinions on Insider Purchases - Quiver Quantitative
Subdued Growth No Barrier To Standard BioTools Inc. (NASDAQ:LAB) With Shares Advancing 26% - simplywall.st
Will Standard BioTools Inc. stock attract ESG investorsQuarterly Growth Report & High Accuracy Buy Signal Tips - Newser
Why Standard BioTools Inc. (FLB) stock is upgraded to buy2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Casdin funds buy Standard Biotools (LAB) shares for $502,570 By Investing.com - Investing.com Australia
Casdin funds buy Standard Biotools (LAB) shares for $502,570 - Investing.com
Casdin Capital, LLC Increases Stake in Standard BioTools Inc - GuruFocus
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - MSN
Why Standard BioTools Inc. (FLB) stock is trending on social mediaEarnings Risk Summary & Free High Return Stock Watch Alerts - Newser
How Standard BioTools Inc. (FLB) stock trades in high volatility2025 Market Sentiment & Daily Price Action Insights - Newser
Why analysts raise outlook for Standard BioTools Inc. (FLB) stock2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Weekly Trades: Will Standard BioTools Inc stock attract ESG investorsJuly 2025 Price Swings & AI Driven Stock Movement Reports - BỘ NỘI VỤ
Standard Biotools Inc (LAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):